CDK7 and cancer: Given that CDK7 is upregulated in cancer cells, CDK7 inhibitors are emerging as a promising chemotherapeutic option to minimize side effects, with some inhibitors having entered clinical trials to treat a variety of cancers (11, 13, 14).